Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvementChristine E. Ryan, Reid W. Merryman, Rebecca L. Zon et al.|British Journal of Haematology|2023Cited by 16
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analysesAlexander Ling, Patrick Y. Wen, Odysseas Nikas et al.|Science Translational Medicine|2025Cited by 12
330 | IDENTIFICATION OF GENOMIC PREDICTORS OF SURVIVAL IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMASElisa Aquilanti, Lakshmi Nayak, T. Aramburu et al.|Hematological Oncology|2025Cited by 0
A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphomaJ. Erika Haydu, Jeremy S. Abramson, Robert Redd et al.|Blood Advances|2025Cited by 0